Skip to main content
    • Aa
    • Aa

Seasonal influenza in the United States, France, and Australia: transmission and prospects for control

  • G. CHOWELL (a1), M. A. MILLER (a2) and C. VIBOUD (a2)

Recurrent epidemics of influenza are observed seasonally around the world with considerable health and economic consequences. A key quantity for the control of infectious diseases is the reproduction number, which measures the transmissibility of a pathogen and determines the magnitude of public health interventions necessary to control epidemics. Here we applied a simple epidemic model to weekly indicators of influenza mortality to estimate the reproduction numbers of seasonal influenza epidemics spanning three decades in the United States, France, and Australia. We found similar distributions of reproduction number estimates in the three countries, with mean value 1·3 and important year-to-year variability (range 0·9–2·1). Estimates derived from two different mortality indicators (pneumonia and influenza excess deaths and influenza-specific deaths) were in close agreement for the United States (correlation=0·61, P<0·001) and France (correlation=0·79, P<0·001), but not Australia. Interestingly, high prevalence of A/H3N2 influenza viruses was associated with high transmission seasons (P=0·006), while B viruses were more prevalent in low transmission seasons (P=0·004). The current vaccination strategy targeted at people at highest risk of severe disease outcome is suboptimal because current vaccines are poorly immunogenic in these population groups. Our results suggest that interrupting transmission of seasonal influenza would require a relatively high vaccination coverage (>60%) in healthy individuals who respond well to vaccine, in addition to periodic re-vaccination due to evolving viral antigens and waning population immunity.

Corresponding author
*Author for correspondence: Dr G. Chowell, Theoretical Division (MS B284), Los Alamos National Laboratory, Los Alamos, NM87544, USA. (Email:
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

2.  L Simonsen . The global impact of influenza on morbidity and mortality. Vaccine 1999; 17 (Suppl 1): S310.

3.  D Weycker , Population-wide benefits of routine vaccination of children against influenza. Vaccine 2005; 23: 12841293.

5.  RM Anderson , RM May . Infectious Diseases of Humans. New York: Oxford University Press, 1991.

7. Macroepidemiology of Influenza Vaccination (MIV) Study Group. The macro-epidemiology of influenza vaccination in 56 countries, 1997–2003. Vaccine 2005; 23: 51335143.

9.  K Goodwin , C Viboud , L Simonsen . Antibody response to influenza vaccination in the elderly: A quantitative review. Vaccine 2005; 24: 11591169.

11.  G Chowell , Transmission dynamics of the great influenza pandemic of 1918 in Geneva, Switzerland: assessing the effects of hypothetical interventions. Journal of Theoretical Biology 2006; 241: 193204.

12.  A Flahault , Modelling the 1985 influenza epidemic in France. Statistics in Medicine 1988; 7: 11471155.

13.  R Gani , Potential impact of antiviral drug use during influenza pandemic. Emerging Infectious Diseases 2005; 11: 13551362.

14.  CE Mills , JM Robins , M Lipsitch . Transmissibility of 1918 pandemic influenza. Nature 2004; 432: 904906.

17.  NM Ferguson , Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature 2005; 437: 209214.

18.  C Viboud , Synchrony, waves, and spatial hierarchies in the spread of influenza. Science 2006; 312: 447451.

19.  C Viboud , Transmissibility and mortality impact of epidemic and pandemic influenza, with emphasis on the unusually deadly 1951 epidemic. Vaccine 2006; 24: 67016707.

20.  L Simonsen , The impact of influenza epidemics on mortality: introducing a severity index. American Journal of Public Health 1997; 87: 19441950.

21.  C Viboud , Multinational impact of the 1968 Hong Kong influenza pandemic: evidence for a smoldering pandemic. Journal of Infectious Diseases 2005; 192: 233248.

23.  TA Reichert , Influenza and the winter increase in mortality in the United States, 1959–1999. American Journal of Epidemiology 2004; 160: 492502.

28.  R Serfling . Methods for current statistical analysis of excess pneumonia-influenza deaths. Public Health Reports 1963; 78: 494506.

29.  C Viboud , Influenza epidemics in the United States, France, and Australia, 1972–1997. Emerging Infectious Diseases 2004; 10: 3239.

30.  V Andreasen . Dynamics of annual influenza A epidemics with immuno-selection. Journal of Mathematical Biology 2003; 46: 504536.

31.  JR Gog , Population dynamics of rapid fixation in cytotoxic T lymphocyte escape mutants of influenza A. Proceedings of the National Academy of Sciences USA 2003; 100: 1114311147.

33.  R Tellier . Review of Aerosol Transmission of Influenza A Virus. Emerging Infectious Diseases 2006; 12: 16571662.

34.  DJ Earn , A simple model for complex dynamical transitions in epidemics. Science 2000; 287: 667670.

35.  IM Longini Jr., Containing pandemic influenza with antiviral agents. American Journal of Epidemiology 2004; 159: 623633.

42.  MJ Ferrari , ON Bjornstad , AP Dobson . Estimation and inference of R0 of an infectious pathogen by a removal method. Mathematical Biosciences 2005; 198: 1426.

43.  RH Alford , Human influenza resulting from aerosol inhalation. Proceedings of the Society for Experimental Biology Medicine 1966; 122: 800804.

45.  B Bean , Survival of influenza viruses on environmental surfaces. Journal of Infectious Diseases 1982; 146: 4751.

46.  JP Leake . The transmission of influenza. Boston Medical and Surgical Journal 1919; 181: 675.

47.  JM Rosenau . Experiments to determine mode of spread of influenza. Journal of the American Medical Association 1919; 73: 311.

52.  RL Riley . Airborne infection. American Journal of Medicine 1974; 57: 466475.

56.  RE Hope-Simpson . The Transmission of Eepidemic Influenza. New York: Plenum Press, 1992.

61.  DJ Smith , Mapping the antigenic and genetic evolution of influenza virus. Science 2004; 305: 371376.

64.  J Dushoff , Dynamical resonance can account for seasonality of influenza epidemics. Proceedings of the National Academy of Sciences USA 2004; 101: 1691516916.

65.  SS Chiu , Influenza-related hospitalizations among children in Hong Kong. New England Journal of Medicine 2002; 347: 20972103.

67.  V Demicheli , Vaccines for preventing influenza in healthy adults. The Cochrane Database of Systematic Reviews 2004; Art. No.: CD001269.

68.  T Jefferson , Assessment of the efficacy and effectiveness of influenza vaccines in healthy children: systematic review. Lancet 2005; 365: 773780.

70.  WP Glezen , L Simonsen . Commentary: benefits of influenza vaccine in US elderly – new studies raise questions. International Journal of Epidemiology 2006; 35: 352353.

71.  C Rizzo , Influenza-related mortality in the Italian elderly: no decline associated with increasing vaccination coverage. Vaccine 2006; 24: 64686475.

74.  IM Longini Jr., ME Halloran . Strategy for distribution of influenza vaccine to high-risk groups and children. American Journal of Epidemiology 2005; 161: 303306.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Epidemiology & Infection
  • ISSN: 0950-2688
  • EISSN: 1469-4409
  • URL: /core/journals/epidemiology-and-infection
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
Type Description Title
Supplementary Materials

Chowell Supplementary Material
Supplementary Material.doc

 Word (608 KB)
608 KB


Altmetric attention score

Full text views

Total number of HTML views: 11
Total number of PDF views: 62 *
Loading metrics...

Abstract views

Total abstract views: 313 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 29th May 2017. This data will be updated every 24 hours.